BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.97B
AUM Growth
-$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$12.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$12M
5
CRL icon
Charles River Laboratories
CRL
+$6.28M

Top Sells

1
+$91.2M
2
+$42.4M
3
+$26.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.3M
5
AXSM icon
Axsome Therapeutics
AXSM
+$14.3M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0.59%
3 Energy 0.02%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$417K 0.01%
4,844
+3,880
152
$323K ﹤0.01%
13,400
153
$291K ﹤0.01%
1,348
154
$283K ﹤0.01%
47,000
155
$179K ﹤0.01%
2,100
156
$174K ﹤0.01%
4,100
157
$147K ﹤0.01%
5,000
158
$147K ﹤0.01%
662
159
$141K ﹤0.01%
170
160
$119K ﹤0.01%
1,300
161
$105K ﹤0.01%
18,000
162
$104K ﹤0.01%
1,600
163
$89K ﹤0.01%
1,050
164
$71K ﹤0.01%
+906
165
$63K ﹤0.01%
301
+108
166
$61K ﹤0.01%
+918
167
$53K ﹤0.01%
+770
168
$47K ﹤0.01%
987
-933
169
$36K ﹤0.01%
246
-257
170
$34K ﹤0.01%
+473
171
$27K ﹤0.01%
135
172
$27K ﹤0.01%
822
+338
173
$23K ﹤0.01%
40
174
$23K ﹤0.01%
739
175
$20K ﹤0.01%
1,130
4 5 6
7
8